U.S. flag

An official website of the United States government

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO DataSets

Items: 20

1.
Full record GDS4600

Psoriasis vulgaris ACCEPT cohort: paired lesional and non-lesional skin

Analysis of 85 paired lesional and non-lesional samples from moderate-to-severe psoriasis patients at baseline without active psoriasis therapy. Results provide insight into the molecular mechanisms underlying psoriasis.
Organism:
Homo sapiens
Type:
Expression profiling by array, transformed count, 2 disease state, 33 individual, 82 other, 10 specimen sets
Platform:
GPL570
Series:
GSE30999
170 Samples
Download data: CEL
2.

Shrinking the Psoriasis assessment gap: Early gene-expression profiling accurately predicts response to long-term treatment

(Submitter supplied) Prediction of response to adalimumab and methotrexate treatments based on gene expression profiles at baseline, weeks 1, 2, 4 and 16
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL10558
179 Samples
Download data: TXT
Series
Accession:
GSE85034
ID:
200085034
3.

Pathologic Immune Pathways in Psoriasis are Rapidly Attenuated by Tofacitinib Treatment: A Randomized Phase 2 Study in Patients with Moderate to Severe Psoriasis

(Submitter supplied) Tofacitinib is an oral Janus kinase inhibitor being investigated for psoriasis. We sought to elucidate the molecular mechanisms underlying the clinical efficacy of tofacitinib in patients with psoriasis. Twelve patients with plaque psoriasis were randomized (3:1) to receive 10 mg of tofacitinib or placebo twice daily for 12 weeks. Biopsy specimens were taken from nonlesional (baseline) and lesional (baseline, days 1 and 3, and weeks 1, 2, 4, and 12) skin. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL570
95 Samples
Download data: CEL
Series
Accession:
GSE69967
ID:
200069967
4.

A Randomized, Placebo-Controlled Study to Evaluate SRT2104, a Selective SIRT1 Activator, in Patients with Moderate to Severe Psoriasis

(Submitter supplied) Activation of Sirtuin (silent mating type information regulation 2 homolog) 1, or SIRT1, is an unexplored therapeutic approach for treatment of inflammatory diseases. The goal of this study was to evaluate the clinical activity and tolerability of multiple doses of SRT2104, a selective activator of SIRT1, in patients with moderate to severe psoriasis after day 84 of treatment. Forty patients were randomized 4:1 to three escalating doses of SRT2104 (250, 500, 1000 mg/d SRT2104 or placebo). more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL570
22 Samples
Download data: CEL
Series
Accession:
GSE50614
ID:
200050614
5.

Expression data from skin biopsy samples from patients with moderate-to-severe psoriasis

(Submitter supplied) A gene expression profiling sub-study was conducted in which skin biopsy samples were collected from 85 patients with moderate-to-severe psoriasis who were participating in ACCEPT, an IRB-approved Phase 3, multicenter, randomized trial. This analysis identified 4,175 probe-sets as being significantly modulated in psoriasis lesions (LS) compared with matched biopsies of non-lesional (NL) skin.
Organism:
Homo sapiens
Type:
Expression profiling by array
Dataset:
GDS4600
Platform:
GPL570
170 Samples
Download data: CEL
Series
Accession:
GSE30999
ID:
200030999
6.

Effective treatment of psoriasis with etanercept is linked to suppression of IL17 signaling, not immediate response TNF

(Submitter supplied) The success of TNF inhibitors for treatment of psoriasis and other inflammatory diseases was previously attributed to blockade of innate immunity. In a clinical trial using etanercept TNF blocking agent to treat psoriasis vulgaris, we used affymetrix gene arrays to analyze broad gene profiles in lesional skin at multiple timepoints during drug treatment (baseline, and weeks 1, 2, 4 and 12) compared to non-lesional skin. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL571
89 Samples
Download data: CEL
Series
Accession:
GSE11903
ID:
200011903
7.

Early quantification of systemic inflammatory (INF) and cardiovascular disease (CVD) proteins predicts long-term treatment response to Tofacitinib and Etanercept

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Homo sapiens
Type:
Other
Platforms:
GPL27152 GPL27151
1020 Samples
Download data
Series
Accession:
GSE136435
ID:
200136435
8.

Early quantification of systemic inflammatory (INF) and cardiovascular disease (CVD) proteins predicts long-term treatment response to Tofacitinib and Etanercept (INF data set)

(Submitter supplied) Proteomic profiles of 92 inflammatory proteins were measured in the blood of psoriasis patients both before and after treatment with tofacitanib or etanercept. These proteomic profiles were used to develop statistical classifiers for predicting PASI75 responses to tofacitinib and etancercept
Organism:
Homo sapiens
Type:
Other
Platform:
GPL27152
528 Samples
Download data: XLSX
Series
Accession:
GSE136434
ID:
200136434
9.

Early quantification of systemic inflammatory (INF) and cardiovascular disease (CVD) proteins predicts long-term treatment response to Tofacitinib and Etanercept (CVD data set)

(Submitter supplied) Proteomic profiles of 91 cardiovascular disease proteins were measured in the blood of psoriasis patients both before and after treatment with tofacitanib or etanercept. These proteomic profiles were used to develop statistical classifiers for predicting PASI75 responses to tofacitinib and etancercept
Organism:
Homo sapiens
Type:
Other
Platform:
GPL27151
492 Samples
Download data: XLSX
Series
Accession:
GSE136431
ID:
200136431
10.

Genome-Wide Profiling of Lesional and Non-Lesional Skin from Atopic Dermatitis, Psoriasis, and Contact Dermatitis Skin

(Submitter supplied) Genome-Wide Profiling of Lesional and Non-Lesional Skin from Atopic Dermatitis, Psoriasis, and Contact Dermatitis Skin
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL6480
75 Samples
Download data: TXT
Series
Accession:
GSE153007
ID:
200153007
11.

Transcriptional Landscape of Psoriasis Identifies the Involvement of IL36 and IL36RN

(Submitter supplied) Background: In present study we performed whole transcriptome analysis in plaque psoriasis patients and compared lesional skin with non-lesional skin and with the skin from healthy controls. We sequenced total RNA from 12 lesional (LP), 12 non-lesional (NLP) and from 12 normal (C) skin biopsies. Results: Compared with previous gene expression profiling studies we had three groups under analysis - LP, NLP and C. more...
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL16288
36 Samples
Download data: TXT
Series
Accession:
GSE66511
ID:
200066511
12.

Comparison of Gene Expression in Psoriatic Skin from Different Sources

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL570
157 Samples
Download data: CEL
Series
Accession:
GSE41664
ID:
200041664
13.

Re-analysis by microarray using cDNA target of samples from psoriasis patients enrolled in an etanercept trial

(Submitter supplied) cDNA and cRNA hybridization technologies have different, probe-specific sensitivities. We used samples from an etanercept trial (GSE11903) to explore in a real-life setting the uniqueness of each platform.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL570
81 Samples
Download data: CEL
Series
Accession:
GSE41663
ID:
200041663
14.

Gene expression profiling in psoriatic lesional and non-lesional skin [Set 2]

(Submitter supplied) To explore the psoriasis phenotype and pathways involved in psoriasis, we characterized gene expression in lesional and non-lesional skin from psoriasis patients.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL570
48 Samples
Download data: CEL
Series
Accession:
GSE41662
ID:
200041662
15.

Gene expression profiling in psoriatic lesional and non-lesional skin [Set 1]

(Submitter supplied) To explore the psoriasis phenotype, we characterize gene expression in lesional and non-lesional skin from psoriasis patients.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL570
28 Samples
Download data: CEL
Series
Accession:
GSE34248
ID:
200034248
16.

Multi-omics profiling reveals the interactions of host defense and hyper-keratinization in psoriasis

(Submitter supplied) Objectives: To understand the crosstalk between the immune system and keratinization in psoriatic skin, using a systems biology approach based on transcriptomics, proteomics and microbiome profiling. Methods: We collected the skin tissue biopsies and swabs in both lesion and non-lesion skin of 13 patients with psoriasis (PsO), 15 patients with psoriatic arthritis (PsA), and healthy skin from 12 patients with ankylosing spondylitis (AS). more...
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL24676
66 Samples
Download data: TXT
17.

Distinct molecular signatures of mild extrinsic and intrinsic atopic dermatitis

(Submitter supplied) Atopic dermatitis (AD) is a common inflammatory skin disease with underlying defects in epidermal function and immune responses. The goal of this study was to investigate differences in gene expression in lesional skin from patients with mild extrinsic or intrinsic AD compared to skin from healthy controls and from lesional psoriasis skin. The aim was to identify differentially expressed genes involved in skin barrier formation and inflammation, and to compare our results with those reported for patients with moderate and severe AD.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL17692
31 Samples
Download data: CEL
Series
Accession:
GSE75890
ID:
200075890
18.

Molecular and cellular profilling of scalp psoriasis reveals differences and similarities compared to skin psoriasis

(Submitter supplied) Scalp psoriasis shows a variable clinical spectrum and in many cases poses a great therapeutic challenge. However, it remains unknown whether the immune response of scalp psoriasis differs from understood pathomechanisms of psoriasis on other skin areas. We sought to determine the cellular and mollecular phenotype of scalp psoriasis by performing a comparative analysis of scalp vs skin using lesional and nonlesional samples from 20 Caucasian subjects with untreated moderate to severe psoriasis and significant scalp involvement, and 10 control subjects without psoriasis. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL571
45 Samples
Download data: CEL
Series
Accession:
GSE75343
ID:
200075343
19.

Expression data from human skin biposies (lesional and uninvolved) from psoriatic patients

(Submitter supplied) Biopsies from uninvolved and from lesional skin of 13 patients with plaque-type psoriasis. Based on paired samples, 179 genes were more than 2-fold differentially expressed in lesional skin. Keywords: Comparison of uninvolved and lesional skin
Organism:
Homo sapiens
Type:
Expression profiling by array
Dataset:
GDS2518
Platform:
GPL96
26 Samples
Download data: CEL
Series
Accession:
GSE6710
ID:
200006710
20.
Full record GDS2518

Psoriatic plaques

Analysis of uninvolved and lesional skin of 13 patients with plaque-type psoriasis. Psoriasis vulgaris is characterized by hyperproliferation and incomplete terminal differentiation of epidermal keratinocytes. Results provide insight into the molecular pathogenesis of psoriasis.
Organism:
Homo sapiens
Type:
Expression profiling by array, count, 2 disease state, 13 individual sets
Platform:
GPL96
Series:
GSE6710
26 Samples
Download data: CEL
DataSet
Accession:
GDS2518
ID:
2518
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

db=gds|term=|query=43|qty=2|blobid=MCID_6659eb34e795547e5f35ac19|ismultiple=true|min_list=5|max_list=20|def_tree=20|def_list=|def_view=|url=/Taxonomy/backend/subset.cgi?|trace_url=/stat?
   Taxonomic Groups  [List]
Tree placeholder
    Top Organisms  [Tree]

Find related data

Support Center